Supplementary materials: Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice BioDay Registry
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://data.mendeley.com/datasets/8bbwkw2xnd
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary materials related to the manuscript entitled “Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice BioDay Registry”
创建时间：
2024-04-16
